Skip to content

72 Investment Holdings, LLC

Follow

13F filer, CIK 1832749, STAMFORD, CT

72 Investment Holdings, LLC reported $38,324,263 across 6 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000902664-25-003658

Period
2025-06-30
Reported value
$38.3M
Holdings
6
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0000902664-25-003658, largest first. % of portfolio is the value over $38,324,263, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LENZLENZ THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,017,751 shares; 2024Q4: 1,017,751 shares; 2025Q1: 1,017,751 shares; 2025Q2: 1,017,751 shares 1,017,751$29.8M77.84%0Timeline
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 276,831 shares; 2024Q4: 276,831 shares; 2025Q1: 276,831 shares; 2025Q2: 276,831 shares 276,831$3.46M9.02%0Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 65,933 shares; 2024Q4: 65,933 shares; 2025Q1: 65,933 shares; 2025Q2: 65,933 shares 65,933$2.77M7.23%0Timeline
ANROALTO NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 667,778 shares; 2024Q4: 667,778 shares; 2025Q1: 667,778 shares; 2025Q2: 667,778 shares 667,778$1.47M3.83%0Timeline
CRBUCARIBOU BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 474,067 shares; 2024Q4: 474,067 shares; 2025Q1: 474,067 shares; 2025Q2: 474,067 shares 474,067$597K1.56%0Timeline
TURNSTONE BIOLOGICS CORPTURNSTONE BIOLOGICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 549,980 shares; 2024Q4: 549,980 shares; 2025Q1: 549,980 shares; 2025Q2: 549,980 shares 549,980$197K0.52%0

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000902664-25-003658 base2025-08-14acceptance time not in the bulk data set